Cargando…
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
House dust mite (HDM) allergen exposure is the most important cause of perennial allergic rhinitis and/or asthma. Although allergen-specific immunotherapy (AIT) with HDM is well established, published studies have been characterized by substantial heterogeneity in clinical endpoints. Standardization...
Autores principales: | Pfaar, Oliver, Gerth van Wijk, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361724/ https://www.ncbi.nlm.nih.gov/pubmed/25798370 http://dx.doi.org/10.1007/s40521-014-0040-y |
Ejemplares similares
-
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020) -
A Precision Medicine Approach to Rhinitis Evaluation and Management
por: Crisci, Carlos D., et al.
Publicado: (2020) -
Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023) -
Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
por: Huang, Yanran, et al.
Publicado: (2019) -
Capsaicin for Rhinitis
por: Fokkens, Wytske, et al.
Publicado: (2016)